2026-04-15 REL RCSB INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY DATABASE_REFERENCES citation citation_author em_admin _em_admin.last_update EXPERIMENTAL_SUMMARY citation citation_author em_admin _em_admin.last_update RCSB RCSB 2025-03-07 2025-07-30 2025-07-30 2026-04-15 National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) United States Cryo-ET map of the VZV capsid vertex (5-fold axis). Oliver SL Chen M Varicella-zoster virus, capsid, cryo-ET, cryo-FIB, VIRUS Oliver SL Chen M Engel L Hecksel CW Zhou X Schmid MF Arvin AM Chiu W Cryogenic electron tomography reveals herpesvirus capsid assembly intermediates inside the cell nucleus. Nat Commun UK 17 2026 41741463 doi:10.1038/s41467-026-69811-4 2041-1723 Oliver SL Chen M Engel L Hecksel CW Zhou X Schmid MF Arvin AM Chiu W Cryogenic Electron Tomography Redefines Herpesvirus Capsid Assembly Intermediates Inside the Cell Nucleus. Biorxiv US 2025 40666836 doi:10.1101/2025.06.27.661840 2692-8205 9no1 FULLOVERLAP EMDB EMD-49591 associated EM volume
Intracellular VZV penton
 Human alphaherpesvirus 3 Human alphaherpesvirus 3 0 1 2 3 4 5 6 7 Human alphaherpesvirus 3 pOka Homo sapiens Capsid 1250.0 16 VIRION SPECIES true false ORF40 Human alphaherpesvirus 3 0.15514535899999998 7 LEVO MTTVSCPANVITTTESDRIAGLFNIPAGIIPTGNVLSTIEVCAHRCIFDFFKQIRSDDNSLYSAQFDILLGTYCNTLNFV RFLELGLSVACICTKFPELAYVRDGVIQFEVQQPMIARDGPHPVDQPVHNYMVKRIHKRSLSAAFAIASEALSLLSNTYV DGTEIDSSLRIRAIQQMARNLRTVLDSFERGTADQLLGVLLEKAPPLSLLSPINKFQPEGHLNRVARAALLSDLKRRVCA DMFFMTRHAREPRLISAYLSDMVSCTQPSVMVSRITHTNTRGRQVDGVLVTTATLKRQLLQGILQIDDTAADVPVTYGEM VLQGTNLVTALVMGKAVRGMDDVARHLLDITDPNTLNIPSIPPQSNSDSTTAGLPVNARVPADLVIVGDKLVFLEALERR VYQATRVAYPLIGNIDITFIMPMGVFQANSMDRYTRHAGDFSTVSEQDPRQFPPQGIFFYNKDGILTQLTLRDAMGTICH SSLLDVEATLVALRQQHLDRQCYFGVYVAEGTEDTLDVQMGRFMETWADMMPHHPHWVNEHLTILQFIAPSNPRLRFELN PAFDFFVAPGDVDLPGPQRPPEAMPTVNATLRIINGNIPVPLCPISFRDCRGTQLGLGRHTMTPATIKAVKDTFEDRAYP TIFYMLEAVIHGNERNFCALLRLLTQCIRGYWEQSHRVAFVNNFHMLMYITTYLGNGELPEVCINIYRDLLQHVRALRQT ITDFTIQGEGHNGETSEALNNILTDDTFIAPILWDCDALIYRDEAARDRLPAIRVSGRNGYQALHFVDMAGHNFQRRDNV LIHGRPVRGDTGQGIPITPHHDREWGILSKIYYYIVIPAFSRGSCCTMGVRYDRLYPALQAVIVPEIPADEEAPTTPEDP RHPLHAHQLVPNSLNVYFHNAHLTVDGDALLTLQELMGDMAERTTAILVSSAPDAGAATATTRNMRIYDGALYHGLIMMA YQAYDETIATGTFFYPVPVNPLFACPEHLASLRGMTNARRVLAKMVPPIPPFLGANHHATIRQPVAYHVTHSKSDFNTLT YSLLGGYFKFTPISLTHQLRTGFHPGIAFTVVRQDRFATEQLLYAERASESYFVGQIQVHHHDAIGGVNFTLTQPRAHVD LGVGYTAVCATAALRCPLTDMGNTAQNLFFSRGGVPMLHDNVTESLRRITASGGRLNPTEPLPIFGGLRPATSAGIARGQ ASVCEFVAMPVSTDLQYFRTACNPRGRASGMLYMGDRDADIEAIMFDHTQSDVAYTDRATLNPWASQKHSYGDRLYNGTY NLTGASPIYSPCFKFFTPAEVNTNCNTLDRLLMEAKAVASQSSTDTEYQFKRPPGSTEMTQDPCGLFQEAYPPLCSSDAA MLRTAHAGETGADEVHLAQYLIRDASPLRGCLPLPR Q4JQT5 Small capsomere-interacting protein Human alphaherpesvirus 3 0.024440118999999996 6 LEVO MTQPASSRVVFDPSNPTTFSVEAIAAYTPVALIRLLNASGPLQPGHRVDIADARSIYTVGAAASAARARANHNANTIRRT AMFAETDPMTWLRPTVGLKRTFNPRIIRPQPPNPSMSLGISGPTILPQKTQSADQSALQQPAALAFSGSSPQHPPPQTTS ASVGQQQHVVSGSSGQQPQQGAQSSTVQPTTGSPPAAQGVPQSTPPPTQNTPQGGKGQTLSHTGQSGNASRSRRV Q4JQV2 ORF20 Human alphaherpesvirus 3 0.054028179999999995 2 LEVO MGSQPTNSHFTLNEQTLCGTNISLLGNNRFIQIGNGLHMTYAPGFFGNWSRDLTIGPRFGGLNKQPIHVPPKRTETASIQ VTPRSIVINRMNNIQINPTSIGNPQVTIRLPLNNFKSTTQLIQQVSLTDFFRPDIEHAGSIVLILRHPSDMIGEANTLTQ AGRDPDVLLEGLRNLFNACTAPWTVGEGGGLRAYVTSLSFIAACRAEEYTDKQAADANRTAIVSAYGCSRMETRLIRFSE CLRAMVQCHVFPHRFISFFGSLLEYTIQDNLCNITAVAKGPQEAARTDKTSTRRVTANIPACVFWDVDKDLHLSADGLKH VFLVFVYTQRRQREGVRLHLALSQLNEQCFGRGIGFLLGRIRAENAAWGTEGVANTHQPYNTRALPLVQLSNDPTSPRCS IGEITGVNWNLARQRLYQWTGDFRGLPTQLSCMYAAYTLIGTIPSESVRYTRRMERFGGYNVPTIWLEGVVWGGTNTWNE CYY Q4JQV5 ORF41 Human alphaherpesvirus 3 0.034421914 4 LEVO MAMPFEIEVLLPGELSPAETSALQKCEGKIITFSTLRHRASLVDIALSSYYINGAPPDTLSLLEAYRMRFAAVITRVIPG KLLAHAIGVGTPTPGLFIQNTSPVDLCNGDYICLLPPVFGSADSIRLDSVGLEIVFPLTIPQTLMREIIAKVVARAVERT AAGAQILPHEVLRGADVICYNGRRYELETNLQHRDGSDAAIRTLVLNLMFSINEGCLLLLALIPTLLVQGAHDGYVNLLI QTANCVRETGQLINIPPMPRIQDGHRRFPIYETISSWISTSSRLGDTLGTRAILRVCVFDGPSTVHPGDRTAVIQV Q4JQT4 ORF43 Human alphaherpesvirus 3 0.07397842999999998 1 LEVO MEAHLANETKHALWHNDHTKGLLHVVIPNAGLIAAGIDPALLILKKPGQRFKVEVQTRYHATGQCEPWCQVFAAYIPDNA LTNLLIPKTEPFVSHVFSATHNSGGLILSLPVYLSPGLFFDAFNVVAIRINTGNRKHRDICIMYAELIPNGTRYFADGQR VLLLCKQLIAYIRCTPRLASSIKIYAEHMVAAMGESHTSNGDNIGPVSSIIDLDRQLTSGGIDDSPAETRIQENNRDVLE LIKRAVNIVNSRHPVRPSSSRVASGLLQSAKGHGAQTSNTDPINNGSFDGVLEPPGQGRFTGKKNNSSASIPPLQDVLLF TPASTEPQSLMEWFDICYAQLVSGDTPADFWKRRPLSIVPRHYAESPSPLIVVSYNGSSAWGGRITGSPILYHSAQAIID AACINARVDNPQSLHVTARQELVARLPFLANVLNNQTPLPAFKPGAEMFLNQVFKQACVTSLTQGLITELQTNPTLQQLM EYDIADSSQTVIDEIVARTPDLIQTIVSVLTEMSMDAFYNSSLMYAVLAYLSSVYTRPQGGGYIPYLHASFPCWLGNRSI YLFDYYNSGGEILKLSKVPVPVALEKVGIGNSTQLRGKFIRSADIVDIGICSKYLPGQCYAYICLGFNQQLQSILVLPGG FAACFCITDTLQAALPASLIGPILDRFCFSIPNPHK Q4JQT2 ORF34 Human alphaherpesvirus 3 0.065253941 2 LEVO MTARYGFGSISFPNKCGIFLSTTKNFIAPNFPIHYWTAPAFELRGRMNPDLEKNTLTLKNAAAVAALDNLRGETITLPTE IDRRLKPLEEQLTRMAKVLDSLETAAAEAEEADAQSEECTRTEIIRNESIHPEVQIAKNDAPLQYDTNFQVDFITLVYLG RARGNNSPGIVFGPWYRTLQERLVLDRPVAARGVDCKDGRISRTFMNTTVTCLQSAGRMYVGDRAYSAFECAVLCLYLMY RTSNSVHEPQVSSFGNLIEHLPEYTETFVNYMTTHENKNSYQFCYDRLPRDQFHARGGRYDQGALTSHSVMDALIRLQVL PPAPGQFNPGVNDIIDRNHTAYVDKIQQAAAAYLERAQNVFLMEDQTLLRLTIDTITALLLLRRLLWNGNVYGDKLKNNF QLGLIVSEATGTPTNNVILRGATGFDGKFKSGNNNFQFLCERYIAPLYTLNRTTELTEMFPGLVALCLDAHTQLSRGSLG RTVIDISSGQYQDRLISLIALELEHRRQNVTSLPIAAVVSIHDSVMLQYERGLGMLMHQPRVRAALEESRRLAQFNVNSD YDLLYFVCLGVIPQFASTP Q4JQU1 Large tegument protein deneddylase Human alphaherpesvirus 3 0.306666938 2 LEVO MDIIPPIAVTVAGVGSRNQFDGALGPASGLSCLRTSLSFLHMTYAHGINATLSSDMIDGCLQEGAAWTTDLSNMGRGVPD MCALVDLPNRISYIKLGDTTSTCCVLSRIYGDSHFFTVPDEGFMCTQIPARAFFDDVWMGREESYTIITVDSTGMAIYRQ GNISFIFDPHGHGTIGQAVVVRVNTTDVYSYIASEYTHRPDNVESQWAAALVFFVTANDGPVSEEALSSAVTLIYGSCDT YFTDEQYCEKLVTAQHPLLLSPPNSTTIVLNKSSIVPLHQNVGESVSLEATLHSTLTNTVALDPRCSYSEVDPWHAVLET TSTGSGVLDCRRRRRPSWTPPSSEENLACIDDGLVNNTHSTDNLHKPAKKVLKFKPTVDVPDKTQVAHVLPRLREVANTP DVVLNVSNVDTPESSPTFSRNMNVGSSLKDRKPFLFEQSGDVNMVVEKLLQHGHEISNGYVQNAVGTLDTVITGHTNVPI WVTRPLVMPDEKDPLELFINLTILRLTGFVVENGTRTHHGATSVVSDFIGPLGEILTGFPSAAELIRVTSLILTNMPGAE YAIKTVLRKKCTIGMLIIAKFGLVAMRVQDTTGALHAELDVLEADLGGSSPIDLYSRLSTGLISILNSPIISHPGLFAEL IPTRTGSLSERIRLLCELVSARETRYMREHTALVSSVKALENALRSTRNKIDAIQIPEVPQEPPEETDIPPEELIRRVYE IRSEVTMLLTSAVTEYFTRGVLYSTRALIAEQSPRRFRVATASTAPIQRLLDSLPEFDAKLTAIISSLSIHPPPETIQNL PVVSLLKELIKEGEDLNTDTALVSWLSVVGEAQTAGYLSRREFDELSRTIKTINTRATQRASAEAELSCFNTLSAAVDQA VKDYETYNNGEVKYPEITRDDLLATIVRATDDLVRQIKILSDPMIQSGLQPSIKRRLETRLKEVQTYANEARTTQDTIKS RKQAAYNKLGGLLRPVTGFVGLRAAVDLLPELASELDVQGALVNLRTKVLEAPVEIRSQLTGDFWALFNQYRDILEHPGN ARTSVLGGLGACFTAIIEIVPIPTEYRPSLLAFFGDVADVLASDIATVSTNPESESAINAVVATLSKATLVSSTVPALSF VLSLYKKYQALQQEITNTHKLTELQKQLGDDFSTLAVSSGHLKFISSSNVDDYEINDAILSIQTNVHALMDTVKLVEVEL QKLPPHCIAGTSTLSRVVKDLHKLVTMAHEKKEQAKVLITDCERAHKQQTTRVLYERWTRDIIACLEAMETRHVFNGTEL ARLRDMAAAGGFDIHAVYPQARQVVAACETTAVTALDTVFRHNPHTPENTNIPPPLALLRGLTWFDDFSITAPVFTVMFP GVSIEGLLLLMRIRAVVLLSADTSINGIPNYRDMILRTSGDLLQIPALAGYVDFYTRSYDQFITESVTLSELRADIRQAA GAKLTEANKALEEVTHVRAHETAKLALKEGVFITLPSEGLLIRAIEYFTTFDHKRFIGTAYERVLQTMVDRDLKEANAEL AQFRMVCQATKNRAIQILQNIVDTANATEQQEDVDFTNLKTLLKLTPPPKTIALAIDRSTSVQDIVTQFALLLGRLEEET GTLDIQAVDWMYQARNIIDSHPLSVRIDGTGPLHTYKDRVDKLYALRTKLDLLRRRIETGEVTWDDAWTTFKRETGDMLA SGDTYATSVDSIKALQASASVVDMLCSEPEFFLLPVETKNRLQKKQQERKTALDVVLQKQRQFEETASRLRALIERIPTE SDHDVLRMLLHDFDQFTHLPIWIKTQYMTFRNLLMVRLGLYASYAEIFPPASPNGVFAPIPAMSGVCLEDQSRCIRARVA AFMGEASVVQTFREARSSIDALFGKNLTFYLDTDGVPLRYRVCYKSVGVKLGTMLCSQGGLSLRPALPDEGIVEETTLSA LRVANEVNELRIEYESAIKSGFSAFSTFVRHRHAEWGKTNARRAIAEIYAGLITTTLTRQYGVHWDKLIYSFEKHHLTSV MGNGLTKPIQRRGDVRVLELTLSDIVTILVATTPVHLLNFARLDLIKQHEYMARTLRPVIEAAFRGRLLVRSLDGDPKGN ARAFFNAAPSKHKLPLALGSNQDPTGGRIFAFRMADWKLVKMPQKITDPFAPWQLSPPPGVKANVDAVTRIMATDRLATI TVLGRMCLPPISLVSMWNTLQPEEFAYRTQDDVDIIVDARLDLSSTLNARFDTAPSNTTLEWNTDRKVITDAYIQTGATT VFTVTGAAPTHVSNVTAFDIATTAILFGAPLVIAMELTSVFSQNSGLTLGLKLFDSRHMATDSGISSAVSPDIVSWGLRL LHMDPHPIENACLIVQLEKLSALIANKPLTNNPPCLLLLDEHMNPSYVLWERKDSIPAPDYVVFWGPESLIDLPYIDSDE DSFPSCPDDPFYSQIIAGYAPQGPPNLDTTDFYPTEPLFKSPVQVVRSSKCKKMPVQPVQPAQPVQPAQPAQPVQPAQPI EPGTQIVVQNFKKPQSVKTTLSQKDIPLYVETESETAVLIPKQLTTSIKTTVCKSITPPNNQLSDWKNNPQQNQTLNQAF NKPILEITSIPTDDSISYRTWIEKSNQTQKRHQNDPRMYNSKTVFHPVNNQLPSWVDTAADAPQTDLLTNYKTRQPSPNF PRDVHTWGVSSNPFNSPNRDLYESDFSEPSDGYSSESENSIVLSLDEHRSCRVPRHVRVVNADVVTGRRYVRGTALGALA LLSQACRRMIDNVRYTRKLLMDHTEDIFQGLGYVKLLLDGTYI Q4JQX9 3.4.19.12 subtomogramAveraging cell 7.4 ETHANE TFS KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 2.7 2.0 5.0 GATAN K3 (6k x 4k) 5760 4092 0.974 1.577 1 C5 8.3 FSC 0.143 CUT-OFF 3804 69 3804 EMAN2 PHASE FLIPPING AND AMPLITUDE CORRECTION OTHER emd_49591.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 192 192 192 0 0 0 192 192 192 660.48 660.48 660.48 90.0 90.0 90.0 X Y Z -7.3818445 14.690272 0.032990295 0.42300716 3.4399998 3.4399998 3.4399998 1.05 AUTHOR Cryo-ET map of the VZV capsid vertex. emd_49591_msk_1.map emd_49591_half_map_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 192 192 192 0 0 0 192 192 192 660.48 660.48 660.48 90.0 90.0 90.0 X Y Z -0.0011264317 0.0016546026 0.000058853613 0.00014608432 3.4399998 3.4399998 3.4399998 AUTHOR Cryo-ET even half map of the VZV capsid vertex. emd_49591_half_map_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 192 192 192 0 0 0 192 192 192 660.48 660.48 660.48 90.0 90.0 90.0 X Y Z -0.0016046771 0.0027673591 0.000059645092 0.00014676631 3.4399998 3.4399998 3.4399998 AUTHOR Cryo-ET odd half map of the VZV capsid vertex.